'Gates' Swing Open to $30M in Genocea Series C Funding
By Randy Osborne
Wednesday, October 10, 2012
Vaccines-focused Genocea Biosciences Inc. added the Bill & Melinda Gates Foundation to its backers as part of a $30 million Series C round that will help advance malaria work, along with programs in herpes simplex virus-2 and Streptococcus pneumoniae.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.